Dr. Véronique Sgambato is a neurobiologist. She obtained her Ph.D. in Neuroscience in 1998 from the University Pierre et Marie Curie in Paris. After studying neuroscience in Canada and the United States, Dr Sgambato came back to France where she obtained an academic position in 2003 as a research scientist at INSERM, the French National Institute of Health and Medical Research. Since January 1st, 2021, she has led a research team entitled “Neuroplasticity in Parkinson’s disease”, aiming at a better understanding of the pathophysiology of the disease with both preclinical and clinical projects. She has been President of the French basal ganglia club and a member of the scientific committee of France Parkinson and Fondation de France. Her work is supported by the CNRS, Université de Lyon, Fondation de France, Fondation Neurodis, France Parkinson, and Agence Nationale de la Recherche. Her research focuses on continued investigations into the role of the dopaminergic and serotonergic systems in the pathophysiology of parkinsonian symptoms.